8-K
Current Report
Outlook Therapeutics, Inc. Filed Acc 0001558370-25-003013
Agreement ended · Bylaws or fiscal year change · Shareholder vote results
- Item 1.02 Termination of a material definitive agreement
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading otlk-20250311x8k.htm…